| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $39.6M | +26.5% |
| SG&A Expense | $22.4M | +14.6% |
| Operating Income | -$62.0M | -24.4% |
| Pre-tax Income | -$60.0M | -20.8% |
| Income Tax | $358K | -29.5% |
| Net Income | -$60.3M | -20.3% |
| EPS (Basic) | -$1.67 | +24.4% |
| EPS (Diluted) | -$1.67 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.2M | +200.3% |
| Short-term Investments | $139.9M | +18.3% |
| Current Assets | $285.2M | +70.8% |
| Total Assets | $287.0M | +70.8% |
| Current Liabilities | $8.5M | +24.2% |
| Long-term Debt | $544K | — |
| Total Liabilities | $10.1M | +29.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.1M | -17.4% |
| Capital Expenditures | $275K | -19.1% |
| Investing Cash Flow | -$22.3M | +81.4% |
| Financing Cash Flow | $167.1M | +24.3% |
| Free Cash Flow | -$49.4M | -17.1% |
| +24.4% |
| Stockholders' Equity |
| $276.9M |
| +72.8% |